Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 286

1.

Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.

Spay C, Meyer G, Lio G, Pezzoli G, Ballanger B, Cilia R, Boulinguez P.

Clin Neurophysiol. 2019 Aug 26;130(11):2065-2075. doi: 10.1016/j.clinph.2019.08.015. [Epub ahead of print]

PMID:
31541984
2.

Freezing of gait in Parkinson's disease reflects a sudden derangement of locomotor network dynamics.

Pozzi NG, Canessa A, Palmisano C, Brumberg J, Steigerwald F, Reich MM, Minafra B, Pacchetti C, Pezzoli G, Volkmann J, Isaias IU.

Brain. 2019 Jul 1;142(7):2037-2050. doi: 10.1093/brain/awz141.

3.

Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.

Barichella M, Cereda E, Pinelli G, Iorio L, Caroli D, Masiero I, Ferri V, Cassani E, Bolliri C, Caronni S, Maggio M, Ortelli P, Ferrazzoli D, Maras A, Riboldazzi G, Frazzitta G, Pezzoli G.

Neurology. 2019 Jul 30;93(5):e485-e496. doi: 10.1212/WNL.0000000000007858. Epub 2019 Jul 5.

PMID:
31278117
4.

Neuronal microtubules and proteins linked to Parkinson's disease: a relevant interaction?

Calogero AM, Mazzetti S, Pezzoli G, Cappelletti G.

Biol Chem. 2019 Aug 27;400(9):1099-1112. doi: 10.1515/hsz-2019-0142. Review.

PMID:
31256059
5.

Monitoring subthalamic oscillations for 24 hours in a freely moving Parkinson's disease patient.

Arlotti M, Palmisano C, Minafra B, Todisco M, Pacchetti C, Canessa A, Pozzi NG, Cilia R, Prenassi M, Marceglia S, Priori A, Rampini P, Barbieri S, Servello D, Volkmann J, Pezzoli G, Isaias IU.

Mov Disord. 2019 May;34(5):757-759. doi: 10.1002/mds.27657. Epub 2019 Mar 20. No abstract available.

6.

Sit-to-walk performance in Parkinson's disease: A comparison between faller and non-faller patients.

Palmisano C, Brandt G, Pozzi NG, Leporini A, Maltese V, Canessa A, Volkmann J, Pezzoli G, Frigo CA, Isaias IU.

Clin Biomech (Bristol, Avon). 2019 Mar;63:140-146. doi: 10.1016/j.clinbiomech.2019.03.002. Epub 2019 Mar 5.

PMID:
30889433
7.

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine.

Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL.

Mov Disord. 2019 Jan;34(1):9-21. doi: 10.1002/mds.27583. Epub 2018 Dec 27. Review.

PMID:
30589955
8.

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.

Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, Ferri V, Cancello R, Ceccarani C, Faierman S, Pinelli G, De Bellis G, Zecca L, Cereda E, Consolandi C, Pezzoli G.

Mov Disord. 2019 Mar;34(3):396-405. doi: 10.1002/mds.27581. Epub 2018 Dec 21.

PMID:
30576008
9.

Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.

Calloni SF, Conte G, Sbaraini S, Cilia R, Contarino VE, Avignone S, Sacilotto G, Pezzoli G, Triulzi FM, Scola E.

Eur J Radiol. 2018 Dec;109:95-100. doi: 10.1016/j.ejrad.2018.10.032. Epub 2018 Nov 1.

PMID:
30527319
10.

Excitability of the supplementary motor area in Parkinson's disease depends on subcortical damage.

Casarotto S, Turco F, Comanducci A, Perretti A, Marotta G, Pezzoli G, Rosanova M, Isaias IU.

Brain Stimul. 2019 Jan - Feb;12(1):152-160. doi: 10.1016/j.brs.2018.10.011. Epub 2018 Oct 23.

11.

Cortical response to levodopa in Parkinson's disease patients with dyskinesias.

Turco F, Canessa A, Olivieri C, Pozzi NG, Palmisano C, Arnulfo G, Marotta G, Volkmann J, Pezzoli G, Isaias IU.

Eur J Neurosci. 2018 Sep;48(6):2362-2373. doi: 10.1111/ejn.14114. Epub 2018 Sep 3.

PMID:
30117212
12.

Pathological Gambling in Parkinson's disease: Autonomic measures supporting impaired decision-making.

Angioletti L, Siri C, Meucci N, Pezzoli G, Balconi M.

Eur J Neurosci. 2019 Aug;50(3):2392-2400. doi: 10.1111/ejn.13993. Epub 2018 Aug 4.

PMID:
29888425
13.

Phase matters: A role for the subthalamic network during gait.

Arnulfo G, Pozzi NG, Palmisano C, Leporini A, Canessa A, Brumberg J, Pezzoli G, Matthies C, Volkmann J, Isaias IU.

PLoS One. 2018 Jun 6;13(6):e0198691. doi: 10.1371/journal.pone.0198691. eCollection 2018.

14.

Nutritional characterisation of Zambian Moringa oleifera: acceptability and safety of short-term daily supplementation in a group of malnourished girls.

Barichella M, Pezzoli G, Faierman SA, Raspini B, Rimoldi M, Cassani E, Bertoli S, Battezzati A, Leone A, Iorio L, Ferri V, Pinelli G, Pusani C, Bolliri C, Cilia R, Caronni S, De Marco P, Cereda E.

Int J Food Sci Nutr. 2019 Feb;70(1):107-115. doi: 10.1080/09637486.2018.1475550. Epub 2018 May 24.

PMID:
29792366
15.

Multiple system atrophy and CAG repeat length: A genetic screening of polyglutamine disease genes in Italian patients.

Mongelli A, Sarro L, Rizzo E, Nanetti L, Meucci N, Pezzoli G, Goldwurm S, Taroni F, Mariotti C, Gellera C.

Neurosci Lett. 2018 Jun 21;678:37-42. doi: 10.1016/j.neulet.2018.04.044. Epub 2018 Apr 30.

PMID:
29715545
16.

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.

Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, Pezzoli G, Langley J, Hu XP, Zucca FA, Isaias IU, Zecca L.

NPJ Parkinsons Dis. 2018 Apr 10;4:11. doi: 10.1038/s41531-018-0047-3. eCollection 2018. Review.

17.

Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson's Disease.

Balconi M, Siri C, Meucci N, Pezzoli G, Angioletti L.

J Parkinsons Dis. 2018;8(2):341-352. doi: 10.3233/JPD-171290.

PMID:
29614700
18.

Gambling behavior in Parkinson's Disease: Impulsivity, reward mechanism and cortical brain oscillations.

Balconi M, Angioletti L, Siri C, Meucci N, Pezzoli G.

Psychiatry Res. 2018 Dec;270:974-980. doi: 10.1016/j.psychres.2018.03.041. Epub 2018 Mar 20.

PMID:
29580652
19.

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1.

Perez Carrion M, Pischedda F, Biosa A, Russo I, Straniero L, Civiero L, Guida M, Gloeckner CJ, Ticozzi N, Tiloca C, Mariani C, Pezzoli G, Duga S, Pichler I, Pan L, Landers JE, Greggio E, Hess MW, Goldwurm S, Piccoli G.

Front Mol Neurosci. 2018 Feb 28;11:64. doi: 10.3389/fnmol.2018.00064. eCollection 2018.

20.

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.

Calogero AM, Viganò M, Budelli S, Galimberti D, Fenoglio C, Cartelli D, Lazzari L, Lehenkari P, Canesi M, Giordano R, Cappelletti G, Pezzoli G.

J Cell Mol Med. 2018 May;22(5):2670-2679. doi: 10.1111/jcmm.13545. Epub 2018 Mar 4.

21.

Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.

Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G.

Parkinsonism Relat Disord. 2018 Apr;49:60-66. doi: 10.1016/j.parkreldis.2018.01.014. Epub 2018 Jan 11.

PMID:
29352722
22.

Factors influencing psychological well-being in patients with Parkinson's disease.

Nicoletti A, Mostile G, Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, De Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Zappia M.

PLoS One. 2017 Dec 15;12(12):e0189682. doi: 10.1371/journal.pone.0189682. eCollection 2017.

23.

Divergent Thinking in Parkinsonism: A Case-Control Study.

Canesi M, Rusconi ML, Cereda E, Ranghetti A, Cereda V, Moroni F, Pezzoli G.

Front Neurol. 2017 Oct 25;8:534. doi: 10.3389/fneur.2017.00534. eCollection 2017.

24.

Evaluating psychiatric symptoms in Parkinson's Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R).

Carrozzino D, Morberg BM, Siri C, Pezzoli G, Bech P.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:131-137. doi: 10.1016/j.pnpbp.2017.10.024. Epub 2017 Nov 1.

PMID:
29100973
25.

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

Angelova PR, Barilani M, Lovejoy C, Dossena M, Viganò M, Seresini A, Piga D, Gandhi S, Pezzoli G, Abramov AY, Lazzari L.

Redox Biol. 2018 Apr;14:474-484. doi: 10.1016/j.redox.2017.10.016. Epub 2017 Oct 20.

26.

Parkin absence accelerates microtubule aging in dopaminergic neurons.

Cartelli D, Amadeo A, Calogero AM, Casagrande FVM, De Gregorio C, Gioria M, Kuzumaki N, Costa I, Sassone J, Ciammola A, Hattori N, Okano H, Goldwurm S, Roybon L, Pezzoli G, Cappelletti G.

Neurobiol Aging. 2018 Jan;61:66-74. doi: 10.1016/j.neurobiolaging.2017.09.010. Epub 2017 Sep 20.

PMID:
29040870
27.

Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.

Brumberg J, Küsters S, Al-Momani E, Marotta G, Cosgrove KP, van Dyck CH, Herrmann K, Homola GA, Pezzoli G, Buck AK, Volkmann J, Samnick S, Isaias IU.

Ann Clin Transl Neurol. 2017 Aug 11;4(9):632-639. doi: 10.1002/acn3.438. eCollection 2017 Sep.

28.

DNAJC12 and dopa-responsive nonprogressive parkinsonism.

Straniero L, Guella I, Cilia R, Parkkinen L, Rimoldi V, Young A, Asselta R, Soldà G, Sossi V, Stoessl AJ, Priori A, Nishioka K, Hattori N, Follett J, Rajput A, Blau N, Pezzoli G, Farrer MJ, Goldwurm S, Rajput AH, Duga S.

Ann Neurol. 2017 Oct;82(4):640-646. doi: 10.1002/ana.25048. Epub 2017 Oct 11.

PMID:
28892570
29.

Erratum to: Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Sep;264(9):2051. doi: 10.1007/s00415-017-8585-x. No abstract available.

30.

Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.

Cilia R, Asselta R, Cereda E, Benfante R, Barbella G, Vallauri D, Marabini L, Fornasari D, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):323-324. doi: 10.1136/jnnp-2017-316235. Epub 2017 Jul 19. No abstract available.

PMID:
28724719
31.

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G.

Neurology. 2017 Aug 1;89(5):432-438. doi: 10.1212/WNL.0000000000004175. Epub 2017 Jul 5.

32.

Dietary habits in Parkinson's disease: Adherence to Mediterranean diet.

Cassani E, Barichella M, Ferri V, Pinelli G, Iorio L, Bolliri C, Caronni S, Faierman SA, Mottolese A, Pusani C, Monajemi F, Pasqua M, Lubisco A, Cereda E, Frazzitta G, Petroni ML, Pezzoli G.

Parkinsonism Relat Disord. 2017 Sep;42:40-46. doi: 10.1016/j.parkreldis.2017.06.007. Epub 2017 Jun 15.

PMID:
28647435
33.

Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Jun;264(6):1254-1263. doi: 10.1007/s00415-017-8523-y. Epub 2017 May 26. Erratum in: J Neurol. 2017 Aug 22;:.

34.

Protein-redistribution diet in a case of tyrosine hydroxylase enzyme deficiency.

Cassani E, Barichella M, Ferri V, Pusani C, Goldwurm S, Siri C, Zini M, Zorzi GS, Cereda E, Iorio L, Pinelli G, Sacilotto G, Pezzoli G.

Mov Disord. 2017 May;32(5):794-795. doi: 10.1002/mds.26963. Epub 2017 Mar 28. No abstract available.

PMID:
28370247
35.

A focus on Rome III criteria for the assessment of constipation in Parkinson's disease.

Barichella M, Cereda E, Cassani E, Frazzitta G, Pezzoli G.

Mov Disord. 2017 Apr;32(4):630. doi: 10.1002/mds.26974. Epub 2017 Mar 25. No abstract available.

PMID:
28343368
36.

Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.

Clerici I, Ferrazzoli D, Maestri R, Bossio F, Zivi I, Canesi M, Pezzoli G, Frazzitta G.

PLoS One. 2017 Feb 3;12(2):e0170927. doi: 10.1371/journal.pone.0170927. eCollection 2017.

37.

Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.

Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, Ghilardi MF, Matthies C, Steigerwald F, Volkmann J, Isaias IU.

Front Hum Neurosci. 2016 Dec 6;10:611. doi: 10.3389/fnhum.2016.00611. eCollection 2016.

38.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, Cirillo M, Tedeschi G, Zanigni S, Calandra-Buonaura G, Tonon C, Pezzoli G, Cilia R, Zappia M, Nicoletti A, Cicero CE, Tinazzi M, Tocco P, Cardobi N, Quattrone A.

Eur Radiol. 2017 Jun;27(6):2665-2675. doi: 10.1007/s00330-016-4622-x. Epub 2016 Oct 19.

PMID:
27761709
39.

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Soldà G, Seresini A, Seia M, Pezzoli G, Goldwurm S.

Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.

PMID:
27632223
40.

α-Synuclein is a Novel Microtubule Dynamase.

Cartelli D, Aliverti A, Barbiroli A, Santambrogio C, Ragg EM, Casagrande FV, Cantele F, Beltramone S, Marangon J, De Gregorio C, Pandini V, Emanuele M, Chieregatti E, Pieraccini S, Holmqvist S, Bubacco L, Roybon L, Pezzoli G, Grandori R, Arnal I, Cappelletti G.

Sci Rep. 2016 Sep 15;6:33289. doi: 10.1038/srep33289.

41.

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.

Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A.

Front Aging Neurosci. 2016 Aug 22;8:196. doi: 10.3389/fnagi.2016.00196. eCollection 2016.

42.

Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease?

Ferrazzoli D, Ortelli P, Maestri R, Bera R, Giladi N, Ghilardi MF, Pezzoli G, Frazzitta G.

Front Aging Neurosci. 2016 Aug 11;8:192. doi: 10.3389/fnagi.2016.00192. eCollection 2016.

43.

Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.

Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, Pinelli G, Privitera G, Cesari I, Faierman SA, Caccialanza R, Pezzoli G, Cereda E.

Neurology. 2016 Sep 20;87(12):1274-80. doi: 10.1212/WNL.0000000000003127. Epub 2016 Aug 19.

PMID:
27543643
44.

Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.

Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L, Ferri V, Privitera G, Pasqua M, Valentino A, Monajemi F, Caronni S, Lignola C, Pusani C, Bolliri C, Faierman SA, Lubisco A, Frazzitta G, Petroni ML, Pezzoli G.

Clin Nutr. 2017 Aug;36(4):1054-1061. doi: 10.1016/j.clnu.2016.06.020. Epub 2016 Jul 5.

PMID:
27406858
45.

Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.

Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.

J Neural Transm (Vienna). 2016 Dec;123(12):1435-1442. doi: 10.1007/s00702-016-1589-3. Epub 2016 Jun 22.

PMID:
27334897
46.

Mechanical Energy Recovery during Walking in Patients with Parkinson Disease.

Dipaola M, Pavan EE, Cattaneo A, Frazzitta G, Pezzoli G, Cavallari P, Frigo CA, Isaias IU.

PLoS One. 2016 Jun 3;11(6):e0156420. doi: 10.1371/journal.pone.0156420. eCollection 2016.

47.

Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.

Cilia R, Benfante R, Asselta R, Marabini L, Cereda E, Siri C, Pezzoli G, Goldwurm S, Fornasari D.

Parkinsonism Relat Disord. 2016 Aug;29:96-103. doi: 10.1016/j.parkreldis.2016.05.017. Epub 2016 May 17.

PMID:
27237108
48.

Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.

Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G.

J Neurol Sci. 2016 Jun 15;365:175-80. doi: 10.1016/j.jns.2016.04.001. Epub 2016 Apr 16.

49.

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.

Canesi M, Giordano R, Lazzari L, Isalberti M, Isaias IU, Benti R, Rampini P, Marotta G, Colombo A, Cereda E, Dipaola M, Montemurro T, Viganò M, Budelli S, Montelatici E, Lavazza C, Cortelezzi A, Pezzoli G.

J Transl Med. 2016 May 10;14(1):127. doi: 10.1186/s12967-016-0880-2.

50.

Sarcopenia and Dynapenia in Patients With Parkinsonism.

Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E.

J Am Med Dir Assoc. 2016 Jul 1;17(7):640-6. doi: 10.1016/j.jamda.2016.03.016. Epub 2016 Apr 30.

PMID:
27143236

Supplemental Content

Loading ...
Support Center